4 Einträge gefunden

1. Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT

   1. Czerw, Tomasz
   2. Iacobelli, Simona
   3. Malpassuti, Vittoria
   4. Koster, Linda
   5. Kröger, Nicolaus
   6. Robin, Marie
   7. Maertens, Johan

   2022 - Forschungsinformationssystem des UKE
2. Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)

   1. Polverelli, Nicola
   2. Mauff, Katya
   3. Kröger, Nicolaus
   4. Robin, Marie
   5. Beelen, Dietrich
   6. Beauvais, David
   7. Chevallier, Patrice

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Antilymphocyte Globulin for matched sibling donor transplantation in patients with myelofibrosis

   1. Robin, Marie
   2. Chevret, Sylvie
   3. Koster, Linda
   4. Wolschke, Christine
   5. Yakoub-Agha, Ibrahim
   6. Bourhis, Jean-Henri
   7. Chevallier, Patrice

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
4. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation

   1. Koenecke, Christian
   2. Göhring, Gudrun
   3. de Wreede, Liesbeth C
   4. van Biezen, Anja
   5. Scheid, Christof
   6. Volin, Liisa
   7. Maertens, Johan

   2015 - Forschungsinformationssystem des UKE - frei zugänglich